Unmodified deoxyoligonucleotides are rapidly degraded in serum-containing medium. Utilizing internally labelled deoxyoligonucleotides the deoxyribonuclease profile for fetal calf serum and human serum was determined. It was found that the predominate nuclease activity in both systems was 3' exonuclease. Deoxyoligonucleotides are protected from exonuclease degradation in sera and cell media by simple terminal modifications that maintain high binding affinity for the complementary DNA sequence.
INTRODUCTION
Sequence-selective inhibition of gene expression in mammalian cell culture has been demonstrated using antisense DNA oligonucleotides 1 -2 . The selectivity and flexibility of the antisense approach makes it an important research tool and an attractive class of therapeutic compounds for serious diseases with known genetic etiologies but poor therapeutic alternatives. Phosphorothioates have been shown to inhibit HIV in vitro by a sequence specific and sequence non-specific mechanism 3 ' 4 . Phosphoroamidate, phosphorothioate, and methane phosphonate oligonucleotide analogues contain substitutions of one of the nonbridging oxygen atoms in the oligonucleotide backbone and are known to significantly enhance nuclease stability in vitro 5 -6 -7 . However, these types of uniform substitutions are known to give depressed hybridization affinities with the complementary DNA sequence 5 -8 . It has been reported that terminal phosphorothioate and methane phosphonate modifications stabilize an oligonucleotide to 3' and 5' exonucleases such as snake venom phosphodiesterase and spleen phosphodiesterase 9 -10 . A recent report has shown that terminal methane phosphonate modifications were useful in protecting deoxyoligonucleotides from exonuclease digestion in fetal calf serum 19 . Reported herein are two classes of conservative chemical modifications which confer protection from enzymatic exonucleolytic degradation. Phosphoroamidate substitutions at the terminal linkages and/or an inverted linkage have been used to stabilize oligonucleotides to exonuclease digestion without compromising binding to the complementary DNA sequence.
Oligonucleotides were modified at the terminal phosphate (3' and/or 5') with phosphoroamidate linkages (3 and 4) to block exonucleolytic degradation. We have termed these terminal modifications as 5' or 3' 'end-caps'. The phosphoroamidate used for these analyses was derived from methoxyethylamine (MEA), as shown in Figure 1 . Using internally labelled oligonucleotide analogues the nuclease profiles of human serum, fetal calf serum, and conditioned cell media were characterized.
EXPERIMENTAL

Synthesis of Deoxyoligonucleotides
Deoxyoligonucleotides were prepared on a Biosearch 8750 DNA synthesizer using standard H-phosphonate chemistry" on controlled pore glass (CPG). Phosphoroamidate and phosphorothioate analogues were prepared by the published procedures 8 -12 . The deoxyoligonucleotides were purified by reverse phase HPLC via DMT-on purification 1314 . The deoxyoligonucleotides with a terminal 3'-3' linkage (5a and 5b) require CPG with the first nucleoside attached via the 5' hydroxl 15 followed by chain elongation in standard 3' -5' fashion.
•^S Labeled Phosphorothioates CPG containing the oligonucleoside H-phosphonate was washed with CH 2 C1 2 , dried from Et 2 O and treated with a mixture of ^Sg (150/tL of 3 mM, 15.2 /iCi//iL) in toluene and 32 S g in pyridine/CSa (1/1, 150/tL of 20 mM). After 2 hr. incubation at room temperature 20 /tL of anhydrous triethylamine was added and the mixture incubated for 16 hr after which time S 8 in pyr/CS2 (400/iL of 200 mM) was added. After 2 hr the CPG was washed with Pyridine/CS, (3x5OO/iL), CH 3 CN (2x5OO/tL) and Et 2 O (2x500/tL). The product was deprotected and removed from the solid support with cone. NH 4 OH (45°C/24hr.), evaporated, taken-up in H 2 O and desalted with a C 8 SPE column (JT Baker), evaporated and used without further purification (specific activity = 1.6X10 9 cpm//imole). 
Thermal Denaturation Measurements
Thermal denaturation was carried out using a Gilford Response II temperature controlled spectrophotometer. The extinction coefficients for the deoxyoligonucleotides were calculated 16 and the final concentration of both strands was ~2 /tM in 150mAf NaCl/10 mM Na 2 HPO 4 (pH = 7.1). The heating rate was 0.5°C/min. from 20°C to 80°C and Tm values were determined by a first derivative plot of absorbance vs temperature.
Cell Culture H938 (human T lymphoma cell lines) were grown in RPM11640 (Gibco) plus 10% heat inactivated fetal calf serum (Gibco, 56°C/4 hrs). The cells were plated at 2 x 10 5 cells/ml into 96 well plates and harvested at different time points.
Human Serum Preparation
Human serum was prepared as follows: freshly drawn human blood was coagulated at room temp for 30 min. Fibrin clots and cells were spun down, the serum (supernatant) was filter-sterilized and added to RPMI 1640 up to 10% for analysis.
RESULTS
Oligonucleotides labelled at the 5'-end using y-^P-ATP and T4 polynucleotide kinase were found to rapidly dephosphorylate when added to cell culture media containing 10% heat-inactivated fetal calf serum, presumably due to high phosphatase activity present in serum (data not shown). In order to stably label oligonucleotides for degradation analyses, oligonucleotides twenty-one bases in length were radiolabelled with 32 P at an internal bridging phosphate by ligation of two shorter oligonucleotides in the presence of a complementary template oligonucleotide (see Materials and Methods). Stability analyses were performed by adding internally-labelled oligonucleotides (1-5) to serum-containing media in H938 human T lymphoma 17 cell culture at a concentration of 10 nA/ either with or without 20 \iM unlabelled oligonucleotide. The oligonucleotides were recovered from the cell media after incubation for variable times and the degree of degradation was analyzed by PAGE. Figure 2a shows a comparison of stability in cellular supernatant for unmodified oligonucleotides (7), 5' and 3' MEA phosphoroamidate end-capped oligonucleotides (3 and 4), and (in Figure 2b ) phosphorothioate oligonucleotides (2). Oligonucleotides containing 5' or 3' terminal phosphoroamidate modifications migrate more slowly on PAGE (higher m/e ratio) than the unmodified diesters".
Under these experimental conditions the 3' end-capped oligonucleotide remains substantially undegraded for up to 7 days. Two 3'-terminal modifications (3) increased the half-life of intact oligonucleotide in 10% heat-inactivated serum from approximately 4 hours for the diester (7) (at 20 \M concentration) to greater than seven days. Phosphoroamidate end-caps at the 5' terminus (4) do not appear to significantly protect oligonucleotides from degradation in the presence of fetal calf serum and, while total amounts of labelled material differ between the two samples, in these analyses, 5' end-capped (4) and unmodified oligonucleotides (7) appeared to have similar patterns of degradation over time (Figure 2a ). When the terminal 3' linkage of the oligonucleotide is inverted, giving rise to a 3'-3' linkage and an oligonucleotide with two 5' ends (5a), it was found to similarly stabilize the deoxyoligonucleotide to degradation in cell culture serum. An inverted diester (5a) was comparable to a phosphoroamidate inverted linkage (5b) (see Table 1 ). Uniformly substituted phosphorothioate oligonucleotides (2) showed little degradation after up to 10 days in cellular supernatant (Figure 2b) .
A comparison of oligonucleotide degradation in fetal calf serum and adult human serum was performed (Figures 3a and 3b) . Four serum conditions were examined, 10% fetal calf serum, 10% heat-inactivated fetal calf serum and two adult human serum samples (one male, one female; see Materials and Methods). In the presence of serum that had not been heat-inactivated, all oligonucleotides tested were degraded more rapidly than in heatinactivated serum (Table 1) . Heat-inactivated fetal calf serum and both adult human serum samples showed similar patterns of oligonucleotide degradation. Oligonucleotides containing 3' phosphoroamidate end-caps (3 and 5) were significantly stabilized in all serum conditions. The effect that these modifications have on the ability of the deoxyoligonucleotide to form duplexes was assessed by Tm analysis. It was found that the 3' end-cap (3) lowered the Tm by 0.5°C and that one 3'-3' linkage (5a) had a similar effect (see Table 1 ). In contrast, the uniformly substituted phosphorothioate (2) destabilized the duplex by 11 °C relative to the diester control Simple 3' terminal modifications of deoxyoligonucleotides were used to protect the oligonucleotides from serum mediated degradation by exonucleases. Using an internally labelled oligonucleotide, the nuclease profile in fetal calf serum and adult human serum was determined to be predominately 3'-exonuclease. Both phosphoroamidate end-capped oligonucleotides and oligonucleotides with a 3'-3' linkage at the 3'-terminus were found to be very useful as terminal modifications to stabilize the oligonucleotides to exonuclease degradation.
DISCUSSION
Oligonucleotides labelled at the 5'-terminal phosphate were found to quickly lose the radiolabel due to high phosphatase activity in serum and conditioned media, making analysis of oligonucleotides by gel electrophoresis nonrepresentative of the total oligonucleotide pool. Internal incorporation of a 32 P label allows a more accurate analysis of oligonucleotide degradation since it does not result in the immediate loss of the radiolabel by phosphatase or exonuclease activity present in serumcontaining media. A similar approach has been used to monitor oligonucleotide stability in oocytes and embryos 14 . Phosphoroamidate modifications of the last two intemucleotide linkages at the 3' end of an oligonucleotide (5) confer significant nuclease stability when the oligonucleotide is added to cell media containing serum. The same modifications at the 5'-terminus (4) did not significantly alter oligonucleotide stability, suggesting that the predominant nuclease activity present in the serum samples tested is a 3' exonuclease. Oligonucleotides containing two methoxyethylamine (MEA) phosphoroamidate substitutions at the 3' end (3) retain excellent binding affinity for complementary DNA with a 0.5°C depression in Tm (Table 1) . Previous studies have shown a large decrease in Tm with uniformly substituted phosphoroamidates and methane phosphonate deoxyoligonucleotides 8 and these results suggest that only one or two such modifications are required for stability to exonuclease digestion 9 ' 10 . Oligonucleotides containing an inverted linkage at the 3'-end (5a and 5b) also stabilize the oligonucleotide to serum mediated degradation and retain excellent binding affinity to the complementary deoxyoligonucleotide (Table 1) . Parallel duplexes have been demonstrated and have been shown to be thermodynamically less stable then antiparallel duplexes 1518 . Although not confirmed, we assume the terminal nucleoside in 5a and 5b is forming a base pair with the terminal nucleoside of the complementary deoxyoligonucleotide but with lower binding affinity. Uniformly substituted phosphorothioates stabilized the oligonucleotide to nuclease digestion but lead to a 11°C depression in Tm relative to phosphodiester oligonucleotide.
Non-heat inactivated fetal calf serum has greater nuclease activity than heat-inactivated fetal calf serum and adult human sera (which are comparable). All serum samples tested have predominately 3'-exonuclease activity. When oligonucleotide stability was assessed using only 10 nM oligonucleotide (radiolabelled material only) degradation was accelerated, suggesting that micromolar concentrations of oligonucleotide may have saturated available nuclease activity. However, the type of degradation seen and the relative stability of the modified oligonucleotides remained the same at all concentrations studied (data not shown). These results suggest that heat-inactivated fetal calf serum represents an accurate model for the nuclease content of human serum.
